The present disclosure relates to systems and methods for characterizing a behavior change of a process. A behavior model that can include a set of behavior parameters can be generated based on behavior data characterizing a prior behavior change of a process. A stimulus parameter for a performance test can be determined based on the set of behavior parameters. An application of the performance test to the process can be controlled based on the stimulus parameter to provide a measure of behavior change of the process. Response data characterizing one or more responses associated with the process during the performance test can be received. The set of behavior parameters can be updated based on the response data to update the behavior model characterizing the behavior change of the process. In some examples, the behavior model can be evaluated to improve or affect a future behavior performance of the process.

The disclosure provides a comprehensive limbal stem cell deficiency diagnostic and staging system that combines observations of physiological parameters such as clinical presentation, central cornea basal cell density, central corneal epithelial thickness, and total corneal nerve fiber length. It has been discovered that the methodology disclosed herein can both accurately and objectively diagnose limbal stem cell deficiency as well as stage its severity.

The head-position sway measuring device (D) includes a touch panel (1a) that gives the instruction to open or close eyes, an acceleration sensor (2a) that measures a displacement of a head position, and a sway recognition unit (1b) that recognizes a head-position sway value based on the displacement of the head position. The acceleration sensor (2a) measures a first measurement value, which is a measurement value obtained in the eye-open state, and then measures a second measurement value, which is a measurement value obtained in the eye-closed state. The sway recognition unit (1b) recognizes the head-position sway value based on the first measurement value and the second measurement value.

An apparatus for making combined vestibular and somatosensory function assessments, comprising: a portable base unit comprising: a movable platform being at least partially rotatable about an axis of rotation; in use, a user stands with both feet on the movable platform; an adjustable stopping mechanism for adjusting an extent to which the movable platform can rotate in at least one direction with respect to a horizontal plane; and a controller for controlling the adjustable stopping mechanism to selectively adjust the extent to which the movable platform is rotated by one of a plurality of discrete measurable amounts based on a control signal; a visual occlusion headset worn by the user, the headset comprising a device for recording a vestibular function response in response to a vestibular function test.

A device for detection of the tactile sensitivity of a user includes a base frame and a mechanical system joined to the base frame, the mechanical system being movable relative to the base frame and having a resting area for the fingertip of at least one finger of the user. The mechanical system includes a plurality of movable plate-shaped members arranged side by side to each other so that the resting area is defined by the thicknesses of at least part of the upper edges of the plate-shaped members. Each plate-shaped member is connected to an actuator, which can be operated to independently move each plate-shaped member from a minimum height position to a maximum height position, a control unit being further provided, which is adapted to operate the actuators.

A system for reducing a kinetosis effect in at least one passenger of a vehicle comprises at least one set of headphones having two loudspeakers and at least one first ear bud, wherein the at least one set of headphones is designed, at least by means of a sensor device integrated in the first ear bud, to detect the kinetosis effect in the auditory canal of the respective passenger via measurement of the body temperature and to provide acoustic signals by means of the two loudspeakers in order to reduce the kinetosis effect of the passenger depending on the kinetosis effect detected. Forces acting on the passenger and their countenance can also be measured.

Apparatus for ophthalmic electrophysiological testing, the apparatus comprising: an EER stimulator for providing an electrical stimulus to an eye so as to evoke an electrophysiological response, wherein the EER stimulator comprises a power source; an amplifier for receiving the electrophysiological response and measuring that response, wherein the amplifier is integrated with the EER stimulator; and at least one switch disposed between the power source and the amplifier for isolating the power source from the amplifier when the electrical stimulus is delivered to the eye.

Provided are a method and an apparatus for measuring an endolymphatic hydrops ratio of inner ear organs using an artificial neural network. The method of measuring an endolymphatic hydrops ratio includes obtaining a plurality of frame images obtained by capturing inner ear organs, obtaining a plurality of pieces of mask data corresponding to each of the plurality of frame images by inputting the plurality of frame images into a neural network, clustering the plurality of pieces of mask data according to the inner ear organs and obtaining representative images according to the inner ear organs according to certain conditions, and overlapping a target image synthesized by using the plurality of frame images and the representative images according to the inner ear organs so as to measure an endolymphatic hydrops ratio.

Methods and systems for use in treating one or more patient’s sensory impairment, e.g., associated with peripheral neuropathy. An exemplary system may be configured to generate treatment information for treating sensory impairment in at least one body portion using photonic energy from a therapeutic laser based on data indicative of damage.

Provided are methods comprising presenting a sensory environment to an individual experiencing the effects of a psychoactive agent, monitoring the neural status, the physiological status, or both, of the individual, and presenting a modified sensory environment to the individual based on the monitoring. In certain embodiments, the agent is a psychedelic agent. According to some embodiments, presenting a sensory environment to the individual comprises presenting to the individual a visual stimulus, an auditory stimulus, a tactile stimulus, an olfactory stimulus, or any combination thereof. In certain embodiments, presenting a modified sensory environment to the individual comprises presenting a customized sensory environment to the individual in real-time based on the monitoring. In some embodiments, the individual is suffering from a mental health condition selected from depression, anxiety, post-traumatic stress disorder (PTSD), addiction, and any combination thereof. Systems that find use in practicing the methods of the present disclosure are also provided.